VNRX — VOLITIONRX LTD
—
NYSE ·
Health Care ·
Life Sciences Tools & Services ·
CIK 93314 ·
Last close
$0.19
Market Cap
$6.81M
52W High
$7.80
52W Low
$0.16
ADV30
3,073,072
Next earnings
2026-11-12
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | 398,657 | — | -4,201,897 | -7,326,047 | 8,300,986 | 2,790,994 | 41,840,346 |
| Mar 2026 | 985,076 | — | -5,228,321 | -6,664,774 | 9,036,483 | 3,102,817 | 42,396,412 |
| Dec 2025 | 447,034 | — | -4,731,280 | -6,270,832 | 6,901,227 | 1,117,028 | 42,494,038 |
| Sep 2025 | 627,277 | — | -4,868,806 | -5,378,358 | 6,448,885 | 199,407 | 42,398,447 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-19,562,408
Investing CF
$-21,969
Financing CF
$20,350,966
CapEx
$-98,752
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-4.04
As of
2026-11-15
Balance + Analyst (yfinance extras)
Retained Earnings
$-267,352,291
Inventory
—
Receivables
$277,355
ST Investments
—
EBIT TTM
$-22,066,011
Pretax Income TTM
$-25,731,452
Interest Exp TTM
$3,665,441
Analysts
5
Yahoo Snapshot (yfinance, live)
Total Revenue
$2,458,044
EBITDA
$-18,572,584
Free Cash Flow
$-9,213,488
Enterprise Value
$9,763,200
Total Cash
$2,790,994
Total Debt
$11,410,300
Shares Out
36,082,903
Trailing EPS
$-3.80
Book Value
$-5.45
ROE
—
ROA
-142.9%
Div Yield
0.00%
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 1,727,384 | -21,222,056 | -23,357,027 | 6,901,227 | 42,494,038 | -34,246,393 | -19,683,334 |
| Dec 2024 | 1,233,511 | -26,921,602 | -26,967,836 | 9,399,523 | 35,507,259 | -24,907,620 | -25,893,624 |
| Dec 2023 | 775,302 | -35,773,244 | -35,319,078 | 27,950,498 | 36,662,720 | -7,802,255 | -18,062,999 |
| Dec 2022 | 306,392 | -30,550,647 | -30,268,793 | 18,295,054 | 21,422,016 | -2,574,991 | -15,277,742 |
TTM Snapshot
Revenues TTM
$2,458,044
NetIncome TTM
$-25,640,011
OpCashFlow TTM
—
Assets (Latest)
$8,300,986
Forward EPS
$-0.85
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| AWHL | Aspira Women's Health Inc. | $7.00M | $0.15 | — |
| BMRA | BIOMERICA INC | $5.68M | $1.24 | — |
| CDIO | Cardio Diagnostics Holdings, Inc. | $5.06M | $1.71 | — |
| TRIB | TRINITY BIOTECH PLC | $4.89M | $6.01 | — |
| VSBC | VITASPRING BIOMEDICAL CO. LTD. | $3.21M | $0.02 | — |
News headlines (Yahoo Finance, 1h cache)
VolitionRx Highlights a Transformational Year: Clinical Validation, Commercial Partnerships, and Potential Upcoming Milestones
2026-11-17 14:31 · Yahoo
Volition Expands Contract with Fujifilm to Include the Nu.Q® Vet Test for Cats
2026-11-16 21:22 · Yahoo
VolitionRx (VNRX) Q3 2026 Earnings Call Transcript
2026-11-13 19:28 · Yahoo
VolitionRx Limited Q3 2026 Earnings Call Summary
2026-11-13 13:30 · Yahoo
VolitionRX: Q3 Earnings Snapshot
2026-11-12 21:41 · Yahoo
VolitionRx Limited Announces Third Quarter 2026 Financial Results and Business Update
2026-11-12 21:10 · Yahoo
VolitionRx Limited Schedules Third Quarter 2026 Earnings Conference Call and Business Update
2026-11-09 21:10 · Yahoo
VolitionRx Signs LOI with Missionpharma to explore the Development and Launch of Volition's Lateral Flow Technology for NETosis Worldwide
2026-10-27 12:47 · Yahoo
VolitionRx Limited Announces $500,000 Partial Pre-Payment of Convertible Note in Cash
2026-10-27 12:17 · Yahoo
VolitionRx Participates in Launch of DETECSEPS Program in France
2026-09-17 12:17 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.